Answers are grounded in this paper and cite their sources.
The diarylquinoline R207910 is in clinical development for tuberculosis treatment. The MIC(50) for 41 drug-susceptible and 44 multidrug-resistant Mycobacterium tuberculosis clinical isolates was 0.032 microg/ml. Out of 20 additional mycobacterial species, three were found to be naturally resistant to R207910 and were shown to exhibit a polymorphism in their atpE genes.
No takes yet. Share an insight, caveat, or question.
Huitric et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: